ALYSSA LAKIN: Open Payments
NPI 1629415922 · MAQUOKETA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,371 in 69 payments from 15 companies in 2025. Trend: 2023 $391 · 2024 $872 · 2025 $1,371
Food & beverage: $1,199Education: $172
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $306 |
| UCB, Inc. | 9 | $183 |
| ABBVIE INC. | 12 | $165 |
| E.R. Squibb & Sons, L.L.C. | 10 | $156 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $68 |
| Organon LLC | 6 | $66 |
| Amgen Inc. | 4 | $65 |
| Arcutis Biotherapeutics, Inc. | 2 | $49 |
Products named: TREMFYA, Bimzelx, Sotyktu, SKYRIZI, LIBTAYO, ILUMYA, RINVOQ, OTEZLA.
Industry payments across IA — which companies pay providers there.
